BOI:EPA
Boiron SA
€18.00
arrow_upward
+0.28%(+0.050) 1D
Oct 22, 5:35:12 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
€17.95
High
€18.00
Low
€17.55
Mkt. cap
315.82M
Avg. vol.
5.50K
Volume
11.88K
P/E ratio
11.93
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
Open
€17.95
High
€18.00
Low
€17.55
Mkt. cap
315.82M
Avg. vol.
5.50K
Volume
11.88K
P/E ratio
11.93
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
News stories
From web sources and news partners
www.marketscreener.com
·
11 minutes ago
S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
TradingView
·
26 minutes ago
Oil Above $110 Sends Fresh Warning to Stock Market
AOL.com
·
29 minutes ago
Costco Turned $1,000 Into $8,018 in Ten Years While the S&P 500 Delivered $3,564
Yahoo Finance
·
58 minutes ago
UBS portfolio manager: S&P 500 could hit 9,500 by June 2027 on AI, longevity, energy boom
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA